Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research agreement with Boehringer Ingelheim to jointly explore the application of ...

A protein created by RFdiffusion3, a newly released protein design tool from Nobel laureate David Baker’s lab, interacting with DNA. (UW Institute for Protein Design / Ian C. Haydon Image) David Baker ...

Artificial intelligence (AI) and "protein language" models can speed the design of monoclonal antibodies that prevent or reduce the severity of potentially life-threatening viral infections, according ...

Forbes contributors publish independent expert analyses and insights. In some of the more sci-fi imaginings of the AI era, there’s this envisioning of “robots making robots,” of software and hardware ...

Siemens Digital Industries Software has updated its Designcenter Solid Edge software. The update includes new capabilities in AI and improvements in productivity, documentation, and user experience.

Accelerating protein production with high reproducibility is a key challenge in drug discovery and development. In this webinar, Karthik Rajasekar from Evotec department of Protein Sciences will ...

Arduino is an open-source hardware and software company that designed one of the most popular single-board microcontrollers (SBMCs) of all time. The Italian company manufactures a variety of different ...

In a deal that surprised some industry observers, chipmaker Qualcomm has agreed to buy Arduino, which is best known for supplying microcontrollers to the DIY community. The acquisition, whose terms ...

The analysis of protein characteristics and interactions is central in drug research. In this web seminar, we will show you how the reliability and robustness of protein characterization can be ...

Two projects at the University of California, Davis, that use artificial intelligence to design and engineer proteins for industrial and health applications have been funded by the U.S. National ...

A Seattle startup company has inked a deal with Eli Lilly to develop AI-powered cancer treatments. The team at Lila Biologics says they're pioneering the translation of AI design proteins for ...

Since its release in 2024, the open-source platform BindCraft, developed at EPFL, has already disrupted the world of protein design. Physical interactions between proteins influence anything from cell ...